Department of Cancer Control and Statistics
Last update Oct 2, 2010
Osaka Cancer Registry
This web site shows outlines, major objectives, and organization of the Osaka Cancer Registry. Recent cancer incidence and survival data in Osaka are summarized and over viewed, together with their time-trends.
Outlines
Osaka Cancer Registry (OCR) has been operating since December 1962 and has accumulated about one million cancer incidence data in Osaka prefecture (April 2010).
Its population was 8.86 million in 2010 census. 97.7% of them were Japanese, 1.4% or 126.5 thousands were Koreans, and 0.6% or 51.1 thousands were Chinese.

Cancer incidence data in Osaka have been reported in Cancer Incidence in Five Continents through volume II - IX. Quality of the data meets a standard level by IACR during recent more than 40 years.
Major object

(1)To estimate incidence rates in Osaka.

(2)To compute statistics on medical treatment conducted for cancer patients in Osaka.
(3)To estimate cancer patient survival.

(4)To assist planning and evaluation of cancer control programs.

(5)To distribute cancer statistics and other information produced at the Registry to the participating
@@medical institutions and health administrators in Osaka to assist and promote their cancer control
@@activities.

(6)To promote the utilization of registry data for epidemiological and clinical studies.

Organization
The Osaka Prefectural Health and Medical Department has been responsible for budgetary support of the registration scheme, collecting cancer death information from health centers, and surveying prognosis of registered cancer cases by the method of referring to inhabitant registers in local municipality offices.
The Osaka Medical Association (OMA) requests all medical institutions located in the Prefecture to cooperate with cancer registration on a voluntary basis. The OMA encourages hospital doctors and general practitioners to prepare cancer reports when they treat cancer cases and to send the reports to the OMA. The OMA is also responsible for promoting the distribution of cancer information from the Registry to participating institutions and medical doctors concerned.
The OCR was set up at the Center for Cancer Control and Statistics (the Director, Hideaki Tsukuma, MD, PhD), the Osaka Medical Center for Cancer and Cardiovascular Diseases, as a central registry responsible for all registry work.

Numbers of incidence, crude incidence rates and age-standardized incidence rates
(per 100,000) by primary site and gender in Osaka, 2006
ICD-10 Numbers of incidence Proportion (%) Crude rates Age-standardized rates*
Male Female Total Male Female Male Female Male Female
All sites C00-C96 21,372 15,308 36,680 100.0 100.0 500.9 337.5 231.8 151.7
Esophagus C15 925 192 1,117 4.3 1.3 21.7 4.2 10.3 1.9
Stomach C16 3,982 1,952 5,934 18.6 12.8 93.3 43.0 42.8 16.9
Colon C18 1,862 1,693 3,555 8.7 11.1 43.6 37.3 20.0 14.1
Rectum C19-C21 1,143 623 1,766 5.3 4.1 26.8 13.7 12.7 6.0
Liver C22 2,313 1,113 3,426 10.8 7.3 54.2 24.5 24.3 8.0
Gallbladder C23-C24 490 527 1,017 2.3 3.4 11.5 11.6 5.0 3.6
Pancreas C25 909 705 1,614 4.3 4.6 21.3 15.5 9.6 5.3
Lung C33-C34 4,106 1,724 5,830 19.2 11.3 96.2 38.0 42.2 13.6
Breast C50 20 2,663 2,683 0.1 17.4 0.5 58.7 0.2 35.4
Uterus (1) C53-C55, D06 1,163 1,066 7.3 25.6 16.8
Uterus (2) C53-C55 909 909 5.9 20.0 11.9
Ovary C56 473 473 3.1 10.4 6.4
Prostate C61 1,508 1,508 7.1 35.3 14.7
Bladder C67 677 199 876 3.2 1.3 15.9 4.4 6.9 1.5
Leukemia C91-C95 344 233 577 1.6 1.5 8.1 5.1 5.1 3.3
"Uterus (1)" includes "In situ cervix uteri", while "Uterus (2)" does not.
"All sites" do not include "In situ cervix uteri" and "In situ breast".
* Standardized to World population.


Time-trends of age-standardized incidence rates (world population, per 100,000) by primary site and gender in Osaka during the periods between 1975 and 2006

Relative 5-year survival of patients diagnosed in Osaka 2002-04 according to primary site
Sites ICD-10 No. of study subjects Relative 5-year survival (%) S.E.(%)
Male Female Total Male Female Total Male Female Total
All sites C00-C96 37,469 28,275 65,744 47.6 58.3 52.1 0.3 0.3 0.2
Esophagus C15 1,701 366 2,067 26.5 31.9 27.5 1.2 2.6 1.1
Stomach C16 8,061 3,699 11,760 56.8 53.0 55.6 0.7 0.9 0.5
Colon C18 3,543 3,126 6,669 66.3 62.0 64.3 1.0 1.0 0.7
Rectum C19-C21 2,391 1,284 3,675 60.2 61.3 60.6 1.2 1.5 0.9
Liver C22 4,052 1,786 5,838 28.3 26.7 27.8 0.8 1.1 0.7
Gallbladder C23-C24 687 751 1,438 16.6 13.6 15.0 1.6 1.4 1.0
Pancreas C25 1,194 924 2,118 5.2 6.2 5.6 0.7 0.8 0.5
Larynx C32 485 43 528 78.0 83.4 78.6 2.5 7.2 2.4
Lung C33-C34 6,209 2,609 8,818 21.5 34.3 25.4 0.6 1.0 0.5
Breast C50 32 6,606 6,638 92.9 87.0 87.0 8.5 0.5 0.5
Uterus C53-C55 2,074 2,074 72.4 72.4 1.1 1.1
Ovary C56 781 781 50.3 50.3 1.9 1.9
Prostate C61 2,696 2,696 89.0 89.0 1.1 1.1
Bladder C67 1,189 312 1,501 76.5 63.5 73.7 1.7 3.3 1.5
Kidney C64-C66,C68 851 407 1,258 62.5 62.6 62.5 2.0 2.7 1.6
Thyroid gland C73 197 572 769 88.2 88.9 88.7 3.2 1.7 1.5
Leukemia C91-C95 580 428 1,008 37.8 44.7 40.7 2.1 2.5 1.6
"Uterus" does not includes "In situ cervix uteri".


Time-trends of relative 5-year survival of patients diagnosed in Osaka

References

1. Ito Y, Ioka A, Nakayama T, Tsukuma H, Nakamura T. Comparison of trends in cancer incidence and mortality in Osaka, Japan, using an age-period-cohort model. Asian Pac J Cancer Prev 2011; 12(4):879-888.

2. Nomura E, Ioka A, Tsukuma H. Trends in the incidence of primary intracranial tumors in Osaka, Japan. Jpn J Clin Oncol 2011; 41(2):291-294.

3. Matsuda T, Ajiki W, Marugame T, Ioka A, Tsukuma H, Sobue T, Research Group of Population-Based Cancer Registries of J. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol 2011; 41(1):40-51.

4. Tanaka H, Tsukuma H, Oshima A. Long-Term Prospective Study of 6104 Survivors of Arsenic Poisoning During Infancy Due to Contaminated Milk Powder in 1955. J Epidemiol. 2010.

5. Baba S, Ioka A, Tsukuma H, Noda H, Ajiki W, Iso H. Incidence and survival trends for childhood cancer in Osaka, Japan, 1973-2001. Cancer Sci. 2010;101(3):787-92.

6. Tanaka M, Tanaka H, Tsukuma H, Ioka A, Oshima A, Nakahara T. Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus. Journal of Viral Hepatitis. 2009;in press.

7. Ioka A, Ito Y, Tsukuma H. Factors relating to poor survival rates of aged cervical cancer patients: a population-based study with the relative survival model in Osaka, Japan. Asian Pac J Cancer Prev. 2009;10(3):457-62.

8. Sato N, Ito Y, Ioka A, Tanaka M, Tsukuma H. Gender differences in stomach cancer survival in Osaka, Japan: analyses using relative survival model. Jpn J Clin Oncol. 2009;39(10):690-4.

9. Ito Y, Ioka A, Tanaka M, Nakayama T, Tsukuma H. Trends in cancer incidence and mortality in Osaka, Japan: Evaluation of cancer control activities. Cancer Sci. 2009;100(12):2390-5.

10. Ito Y, Ioka A, Tsukuma H, Ajiki W, Sugimoto T, Rachet B, Coleman MP. Regional differences in population-based cancer survival between six prefectures in Japan: application of relative survival models with funnel plots. Cancer Sci. 2009;100(7):1306-11.

11. Toyoda Y, Nakayama T, Ito Y, Ioka A, Tsukuma H. Trends in colorectal cancer incidence by subsite in Osaka, Japan. Jpn J Clin Oncol. 2009;39(3):189-91.

12. Tanaka H, et al. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Int Med (2008) 148: 820-826.

13. Tabata N, et al. Partial cancer prevalence in Japan up to 2020: Estimates based on incidence and survival data from population-based cancer registries. Jpn J Clin Oncol (2008) 38: 146-157.

14. Ioka A, et al. Hospital procedure volume and survival of cancer patients in Osaka, Japan: a population-based study with latest cases. Jpn J Clin Oncol (2007) 37: 544-553.

15. Ito Y, et al. Cancer survival trends in Osaka, Japan: the influence of age and stage at diagnosis. Jpn J Clin Oncol (2007) 37: 452-458.

16. Saika K, et al. The trend of the effect of surgical volume up to 5 years after resection for stomach and lung cancer patients. Jpn J Applied IT Healthcare (2007) 1: 42-49.

17. Matsuno R, et al. Early- and late-onset breast cancer types among women in theUnited States and Japan. Cancer Epidemiol Biomarkers Prev (2007) 16: 1437–42.

18. Tanaka H, et al. Distinctive change in male liver cancer incidence rate between the 1970s and 1990s in Japan: comparison with Japanese-American and US whites. Jpn J Clin Oncol (2007) 37: 193-196.

19. Kanazawa N, et al. Incidence and survival of mesothelioma in Osaka, Japan. Jpn J Clin Oncol (2006) 36: 254-257.

20. Nomura E, et al. Population-based study of relationship between the hospital surgical volume and the 10-year survival of breast cancer patients in Osaka, Japan. Cancer Science (2006) 97: 618-622.

21. Ueda K, et al. Cervical and corpus cancer survival disparities by socioeconomic status in a metropolitan area of Japan. Cancer Science (2005) 97: 283-291.

22. Ueda K, et al. Socioeconomic factors and cancer incidence, mortality, and survival in a metropolitan area of Japan: A cross-sectional ecological study. Cancer Science (2005) 96: 684-688.

23. Ioka A, et al. Influence of hospital procedure volume on uterine cancer survival in Osaka, Japan. Cancer Science (2005) 96: 689-694.

24. Ioka A, et al. Trends in head and neck cancer incidence in Japan during 1965-1999. Jpn J Clin Oncol (2005) 35: 45-47.

25. Ioka A, et al. Influence of age on cervical cancer survival in Japan. Jpn J Clinic Oncol (2005) 35: 464-469.

26. Tsukuma H, et al. Liver cancer and its prevention. Asian Pacific Journal of Cancer Prevention (2005) 6: 1-7.

27. Kitamura Y, et al. Statistical estimation of the number of breast cancer patients with disabilities resulting from surgery. Breast Cancer (2005) 12: 130-134.

28. Ajiki W, et al. Cancer incidence rates in Jpan in 1999: Estimates based on data from 11 population-based cancer registries. Jpn J Clim Oncol (2004) 34: 352-356.

29. Ajiki W, et al. Survival rates of childhood cancer patients in Osaka, Japan. Jpn J Clin Oncol (2004) 34:50-54.

30. Ioka A, et al. Influence of hospital procedure volume on ovarian cancer survival in Japan, a country with low incidence of ovarian cancer. Cancer Sci (2004) 95: 233-237.

31. Tsukuma H, et al. Cancer Incidence in Japan. Cancer Mortality and Morbidity Statistics: Japan and the World-2004, Tajima K, Kuroishi T, Oshima A (ed), Gann Monograph on Cancer Research (2004) No. 51: 95-130, Japan Sci Soc Press, Tokyo.

32. Ajiki W, et al. Trends in cancer incidence and survival in Osaka. Cancer Mortality and Morbidity Statistics: Japan and the World-2004, Tajima K, Kuroishi T, Oshima A (ed), Gann Monograph on Cancer Research (2004) No. 51: 137-163. Japan Sci Soc Press, Tokyo.

33. Ioka A, et al. Ovarian cancer incidence and survival by histologic type in Osaka, Japan. Cancer Sci (2003) 94: 292-296.

34. Honjo S, et al. Neuroblastoma trends in Osaka, Japan, and Great Britain 1970-1994, in relation to screening. Int J Cancer (2003) 103: 538-43.

35. Yoshimi I, et al. A comparison of trends in the incidence of lung cancer by histological type in the Osaka cancer Registry, Japan and in the Surveillance, Epidemiology and End Results Program, USA. Jpn J Clin Oncol (2003) 33: 98-104.

36. Ueda K, et al. Estimation of individualized probabilities of developing breast cancer for Japanese women. Breast Cancer (2003) 10: 54-62.

37. Nomura E, et al. Population-based study of relationship between hospital surgical volume and 5-year survival of stomach cancer patients in Osaka, Japan. Cancer Sci (2003) 94:998-1002.

38. Ioka A, et al. Trends of uterine cancer incidence in Japan in 1975-1998. Jpn J Clin Oncol (2003) 33: 645-646.

39. Verdecchia A, et al. Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer (2003) 39: 1603-1609.

40. Lambert R, et al. Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer (2002) 97: 811-8.